Clinical Trials Directory

Trials / Completed

CompletedNCT04127513

Comparison of 12% Ammonium Lactate and 10% Urea Cream in Geriatric With Xerosis Cutis

Comparison of Efficacy and Safety Between Moisturising Cream Containing 12% Ammonium Lactate AND 10% Urea in Geriatric With Xerosis Cutis: Double Blind Randomised Controlled Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Indonesia University · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

This study aims to compare the efficacy and safety between moisturizing cream containing 12% ammonium lactate and 10% urea in geriatric with xerosis cutis. A double-blind randomized controlled trial with matching paired subject was conducted on 40 residents of a nursing home in Jakarta. Specified symptom sum score (SRRC), skin capacitance (SCap), transepidermal water loss (TEWL), and side effects were measured at baseline, week-2 and week-4 after therapy, and week-5 one week after therapy cessation. After a week of preconditioning, each subject received two different moisturizing creams to be applied on separate lower limbs.

Detailed description

Dry skin or xerosis cutis is widely known skin health issue in geriatric population with prevalence rate ranges between 29.5 - 85.5%. One of the internal etiological factors is decreased production of natural moisturizing factor as a humectant. Application of moisturizer is the mainstay treatment. Moisturizer with humectant property, like lactate and urea, could restore skin hydration and barrier dysfunction. This study aims to compare the efficacy and safety between moisturizing cream containing 12% ammonium lactate and 10% urea in geriatric with xerosis cutis.

Conditions

Interventions

TypeNameDescription
DRUGAmmonium Lactate12% ammonium lactate moisturizing cream
DRUGUrea10% urea moisturizing cream

Timeline

Start date
2017-04-01
Primary completion
2017-05-31
Completion
2017-05-31
First posted
2019-10-15
Last updated
2019-10-15

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT04127513. Inclusion in this directory is not an endorsement.